By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


CFR Pharmaceuticals 

Av.Pedro de Valdivia 295

Providencia  Santiago    Chile
Phone: 56-2-350-5214 Fax: 56-2-350-5212



Company News
Abbott Laboratories (ABT) Commences Tender Offer For All Outstanding Ordinary Shares And American Depositary Shares Of CFR Pharmaceuticals 8/25/2014 8:57:09 AM
Fitch Places CFR Pharmaceuticals's IDRs On Rating Watch Positive On Proposed Acquisition By Abbott Laboratories (ABT) 5/20/2014 8:59:09 AM
Abbott Laboratories (ABT) Expands Latin American Presence And Branded Generics Portfolio With Acquisition Of CFR Pharmaceuticals 5/16/2014 7:22:48 AM
CFR Pharmaceuticals Announces Exemption From The Takeover Regulation Panel ("TRP") And Confirmation That The Termination Agreement Concluded On 7 February 2014 ("Termination Agreement") Is Now Effective 2/13/2014 9:26:50 AM
Joint Announcement Regarding The Intended Consensual Termination Of The Transaction Implementation Agreement ("TIA") Between Adcock Ingram And CFR Pharmaceuticals ("The Parties") 2/7/2014 9:19:59 AM
CFR Pharmaceuticals Announces Further Extension To The Date For Fulfilment Or Waiver Of The Pre-Conditions To The Revised Scheme Consideration 1/21/2014 8:53:58 AM
Adcock Ingram Suspends Dividend as Takeover Talks With CFR Pharmaceuticals Continue 11/27/2013 6:51:31 AM
Distribution Of Circular To Adcock Ingram Shareholders In Respect Of A Scheme Of Arrangement And Posting Of CFR Pharmaceuticals Combined Prospectus And Pre-Listing Statement 11/20/2013 8:50:40 AM
Announcement Of A Firm Intention By CFR Pharmaceuticals To Acquire 100% Of The Issued Share Capital Of Adcock Ingram By Way Of A Scheme Of Arrangement 11/18/2013 9:35:59 AM
CFR Pharmaceuticals Announces Consolidated Results for the Third Quarter 2013 11/14/2013 12:53:58 PM